Elmiron Vision Side Effects May Cause Pigmentary Maculopathy
April 2026 Update: Saiontz & Kirk is no longer filing new Elmiron lawsuits. This page is for informational and historical purposes only.
The product liability lawyers at Saiontz & Kirk previously investigated potential lawsuits for users of the interstitial cytisis/bladder pain syndrome drug Elmiron, which may have caused a type of retina damage and vision loss known as pigmentary maculopathy.
Lawsuits claimed the medication was allegedly sold for decades without proper warnings about the importance of monitoring for Elmiron vision side effects, which may have surfaced with symptoms such as:
- Progressive vision loss or deterioration of the eyes;
- Blurry vision or distorted vision;
- Difficulty reading;
- Prolonged dark adaption or problems seeing at night;
- Loss of detailed vision;
- Darkening vision;
A series of case reports and studies have been published highlighting the growing evidence about a link between Elmiron and eye problems involving an atypical maculopathy that may worsen over time and result in permanent retinal injury.
As a result of the drug manufacturers failure to adequately warn about the potential Elmiron side effects on vision, many ophthalmologists were unaware of the drug toxicity on the retina and users were often misdiagnosed and kept on the drug, potentially worsening the eye damage.
This condition was often referred to in lawsuits and medical research as Elmiron maculopathy or pigmentary maculopathy. In some cases, individuals who later pursued Elmiron lawsuits alleged that their vision problems were initially diagnosed under other names or as other retinal diseases, including:
- Age-Related Macular Degeneration (AMD)
- Macular Retinopathy
- Pattern Distrophy
- Retinal Macular Dystrophy
- Macular Toxicity
- Retinal Pigmentary Changes
- Other Maculopathy
Elmiron lawsuits alleged that Janssen Pharmaceuticals knew or should have known about potential vision risks linked to long-term use of the drug and failed to provide adequate warnings to users and the medical community.
UPDATE: In June 2020, the drug makers updated the warning label, providing information for the first time about the potential link between Elmiron and eye damage. However, this information comes too late for thousands of long-term users who have already been left with irreversible retina damage and pigmentary changes that may have been avoided or less serious if earlier information had been disclosed.
Elmiron Vision Loss Lawyers
Elmiron vision loss lawsuits previously handled by Saiontz & Kirk were pursued under a contingency fee agreement. This meant clients did not pay out-of-pocket attorney fees or case expenses unless a settlement or other recovery was obtained.
Saiontz & Kirk is no longer filing new Elmiron vision loss lawsuits. This information is provided for historical purposes only.
No Comments • Add Your Comments